Syncom Formulation (India) Ltd

NSE: SYNCOMF · BSE: 524470 · Pharmaceuticals & Biotechnology · 22 announcements

Share price: ₹24.72
Market cap: ₹2,324 Cr
Revenue (annual): ₹489.2 Cr
Net profit (annual): ₹76.44 Cr
P/E (TTM): 27.2×Sector 47.4×
Promoter holding: 50.57%+0.00% QoQ
FII holding: 0.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 8 Financial Results 3 Board Meeting Date 2 Annual General Meeting 2 Results Update 1 Management Change 1 Dividend 1 Debt & Borrowing 1 Capacity Expansion 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

11 Aug 2026 18:23 IST BSE

Financial Results

Syncom Formulation (India) Q1 FY27 Results: Net Profit ₹24.8 Cr, Up 57.0% YoY

Syncom Formulation (India) Ltd reported revenue from operations of ₹125.5 Cr (+7.4% YoY) and net profit of ₹24.8 Cr (+57.0% YoY) for Q1 FY27.

Key figure: Net profit ₹24.8 Cr · +57.0% YoY

Open full results → Read the filing ↗

22 May 2026 18:34 IST BSE

Financial Results

Syncom Formulation (India) Q4 FY26 Results: Net Profit ₹25.2 Cr, Up 42.4% YoY

Syncom Formulation (India) Ltd reported revenue from operations of ₹135.4 Cr (-9.1% YoY) and net profit of ₹25.2 Cr (+42.4% YoY) for Q4 FY26.

Key figure: Net profit ₹25.2 Cr · +42.4% YoY

Open full results → Read the filing ↗

22 May 2026 18:33 IST BSE

Financial Results

Syncom Formulation (India) Financial Results

Syncom Formulations (India) Limited reported audited consolidated net profit of ₹76.44 Crore for FY2026. The board approved results showing significant annual revenue growth to ₹520.51 Crore.

Read the filing ↗